← Leaderboards
Jay H Fowke
University Of South Carolina At Columbia
$7,274,398
Attributed
$7,394,398
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,038,397 · 17
By mechanism
R01$6,020,661 · 3
P20$918,320 · 2
R03$477,125 · 3
R21$298,414 · 1
U54$240,000 · 1
M01$83,877 · 7
Top collaborators
- Simon W. Hayward1 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Narendra P Singh$5,323,240
- Baoting Zhu$3,069,030
- James R Hebert$10,782,182
- Chuanbing Tang$3,895,491
- Sarah E Rothenberg$1,786,804
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityBiopsyMalignant Neoplasm Of ProstateResearch PersonnelStructureBaseCommunitiesPathway InteractionsLinkClinical ResearchProstateQuestionnairesBiomarkerFutureUrineEstrogensRecruitment ActivityResourcesBloodMorbidity - Disease RateAdipose TissueHuman SubjectCountryPattern
Grant awards (37)
Vanderbilt Developmental Center for Translational Research in Benign Urologic Diseases$315,146
P20 · FY2017 · DK · contact PI
Admin-Core: Vanderbilt Developmental Center for Translational Research in Benign Urologic Diseases$168,273
P20 · FY2017 · DK · contact PI
Vanderbilt Developmental Center for Translational Research in Benign Urologic Diseases$328,853
P20 · FY2016 · DK · contact PI
Admin-Core: Vanderbilt Developmental Center for Translational Research in Benign Urologic Diseases$106,048
P20 · FY2016 · DK · contact PI
Mechanisms of BPH Progression$240,000
U54 · FY2015 · DK
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression$329,396
R01 · FY2013 · DK · contact PI
A New Instrument to Comprehensively Assess Sedentary Behaviors$237,836
R01 · FY2013 · NR · contact PI
Modifiable Risk Factors for Fatal Prostate Cancer: A Prospective Study In Asia$80,808
R03 · FY2013 · CA · contact PI
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression$12,477
R01 · FY2013 · DK · contact PI
A New Instrument to Comprehensively Assess Sedentary Behaviors$364,256
R01 · FY2012 · NR · contact PI
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression$344,142
R01 · FY2012 · DK · contact PI
Modifiable Risk Factors for Fatal Prostate Cancer: A Prospective Study In Asia$99,966
R03 · FY2012 · CA · contact PI
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer$527,769
R01 · FY2011 · CA · contact PI
A New Instrument to Comprehensively Assess Sedentary Behaviors$391,116
R01 · FY2011 · NR · contact PI
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression$342,730
R01 · FY2011 · DK · contact PI
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer$564,901
R01 · FY2010 · CA · contact PI
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression$401,472
R01 · FY2010 · DK · contact PI
A New Instrument to Comprehensively Assess Sedentary Behaviors$400,286
R01 · FY2010 · NR · contact PI
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer$571,978
R01 · FY2009 · CA · contact PI
A New Instrument to Comprehensively Assess Sedentary Behaviors$386,685
R01 · FY2009 · NR · contact PI
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer$569,548
R01 · FY2008 · CA · contact PI
PROSTATE CANCER AND PSA RECURRENCE$504
M01 · FY2008 · RR · contact PI
ADIPOSE-RELATED BIOMARKERS OF PROSTATE CANCER, NASHVILLE MEN'S HEALTHY STUDY$47
M01 · FY2008 · RR · contact PI
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer$576,069
R01 · FY2007 · CA · contact PI
PROSTATE CANCER AND PSA RECURRENCE$10,692
M01 · FY2007 · RR · contact PI
ADIPOSE-RELATED BIOMARKERS OF PROSTATE CANCER, NASHVILLE MEN'S HEALTHY STUDY$994
M01 · FY2007 · RR · contact PI
PROSTATE CANCER AND PSA RECURRENCE$11,745
M01 · FY2006 · RR · contact PI
ESTROGENS, HGPIN, AND PROSTATE CANCER$3,223
M01 · FY2005 · RR
Adipose-Related Biomarkers of Prostate Cancer$151,000
R21 · FY2004 · CA
Estrogens, HGPIN, and Prostate Cancer$39,065
M01 · FY2004 · RR
Effects pf Brassica on Markers of Colon Cancer Risk$17,607
M01 · FY2004 · RR
Adipose-Related Biomarkers of Prostate Cancer$147,414
R21 · FY2003 · CA
ISOTHIOCYANATE EXCRETION, BRASSICA, AND BREAST CANCER$75,604
R03 · FY2002 · CA
Effects of Brassica on Markers of Colon Cancer Risk$75,500
R03 · FY2002 · CA
Effects of Brassica on Markers of Colon Cancer Risk$71,081
R03 · FY2001 · CA
ISOTHIOCYANATE EXCRETION, BRASSICA, AND BREAST CANCER$41,458
R03 · FY2001 · CA
ISOTHIOCYANATE EXCRETION, BRASSICA, AND BREAST CANCER$32,708
R03 · FY2001 · CA